{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:04Z","timestamp":1791296764386,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"HPI"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.05.075","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T11:35:00Z","timestamp":1339587300000},"page":"5086-5093","source":"Crossref","is-referenced-by-count":42,"title":["Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis"],"prefix":"10.1016","volume":"30","author":[{"given":"Maria","family":"Agallou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Smirlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty P.","family":"Soteriadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Karagouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.05.075_bib0005","unstructured":"World Health Organization [Internet]. Geneva, Switzerland; 2011. Available from: http:\/\/www.who.int\/leishmaniasis\/en\/index.html."},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.075_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1590\/S0100-879X2004000400020","article-title":"Immunity and immunosuppression in experimental visceral leishmaniasis","volume":"37","author":"Goto","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.075_bib0015","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.075_bib0020","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.075_bib0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","article-title":"Identification and characterization of T cell-stimulating antigens from Leishmania by CD4T cell expression cloning","volume":"166","author":"Probst","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(04)00044-3","article-title":"The nucleosome: from genomic organization to genomic regulation","volume":"116","author":"Khorasanizadeh","year":"2004","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.075_bib0035","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1128\/IAI.70.12.6976-6986.2002","article-title":"Expression of a novel Leishmania gene encoding a histone H1-like protein in Leishmania major modulates parasite infectivity in vitro","volume":"70","author":"Papageorgiou","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0166-6851(93)90123-F","article-title":"Identification of a histone H1-like gene expressed in Leishmania major","volume":"62","author":"Fasel","year":"1993","journal-title":"Mol Biochem Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.075_bib0045","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1365-2958.2006.05205.x","article-title":"Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo","volume":"60","author":"Smirlis","year":"2006","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.075_bib0050","first-page":"808","article-title":"Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants","volume":"9","author":"Carmelo","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2249.1999.00796.x","article-title":"Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis","volume":"115","author":"Soto","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.075_bib0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.d01-865.x","article-title":"Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis","volume":"106","author":"Soto","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.075_bib0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-2478(95)02473-5","article-title":"Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis","volume":"48","author":"Soto","year":"1995","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.075_bib0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0169-4758(00)01651-3","article-title":"Evolutionarily conserved proteins as prominent immunogens during Leishmania infections","volume":"16","author":"Requena","year":"2000","journal-title":"Parasitol Today"},{"issue":"20","key":"10.1016\/j.vaccine.2012.05.075_bib0075","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.vaccine.2008.03.003","article-title":"Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells","volume":"26","author":"Carrion","year":"2008","journal-title":"Vaccine"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2012.05.075_bib0080","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2004.04.015","article-title":"Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis","volume":"22","author":"Iborra","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.075_bib0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.micinf.2007.02.018","article-title":"Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB\/c mice","volume":"9","author":"Carrion","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2012.05.075_bib0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.05.075_bib0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.075_bib0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2008.12.012","article-title":"CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases","volume":"61","author":"Klinman","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.075_bib0105","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.4049\/jimmunol.170.6.3171","article-title":"Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens","volume":"170","author":"Berberich","year":"2003","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.075_bib0110","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.170.11.5625","article-title":"Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis","volume":"170","author":"Ghosh","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.075_bib0115","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.4049\/jimmunol.163.7.3890","article-title":"Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection","volume":"163","author":"Ahuja","year":"1999","journal-title":"J Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2012.05.075_bib0120","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2012.05.075_bib0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0264-410X(97)00308-3","article-title":"ISCOMs vaccine against experimental leishmaniasis","volume":"16","author":"Papadopoulou","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.075_bib0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carrion","year":"2006","journal-title":"Parasite Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2012.05.075_bib0135","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.160197797","article-title":"The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge","volume":"97","author":"Stobie","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2012.05.075_bib0140","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major","volume":"27","author":"Bhaumik","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2012.05.075_bib0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1286-4579(01)01426-5","article-title":"Protective immune response against cutaneous leishmaniasis by prime\/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36\/LACK and IL-12 in combination with purified p36","volume":"3","author":"Gonzalo","year":"2001","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1383-5769(01)00070-8","article-title":"A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB\/c mice from Leishmania major infection","volume":"50","author":"Yamakami","year":"2001","journal-title":"Parasitol Int"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.075_bib0155","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/378677","article-title":"Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen","volume":"188","author":"Masina","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0160","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N","article-title":"Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani","volume":"28","author":"Engwerda","year":"1998","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.075_bib0165","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/IAI.63.12.4894-4899.1995","article-title":"Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection","volume":"63","author":"Satoskar","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.075_bib0170","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/IAI.62.3.1058-1063.1994","article-title":"Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.075_bib0175","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1073\/pnas.97.7.3406","article-title":"Potent induction of long-term CD8+ T cell memory by short-term IL-4 exposure during T cell receptor stimulation","volume":"97","author":"Huang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.075_bib0180","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-2478(03)00021-X","article-title":"Infection pattern and immune response in the spleen and liver of BALB\/c mice intracardially infected with Leishmania donovani amastigotes","volume":"86","author":"Mukherjee","year":"2003","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.075_bib0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"Melby","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2567.2000.00939.x","article-title":"Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen","volume":"99","author":"Basu","year":"2000","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.075_bib0200","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.96.12.6970","article-title":"Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms","volume":"96","author":"Walker","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"10.1016\/j.vaccine.2012.05.075_bib0205","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.075_bib0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-4017(98)00240-4","article-title":"Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum","volume":"81","author":"Rhalem","year":"1999","journal-title":"Vet Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.075_bib0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/107999000312748","article-title":"The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice","volume":"20","author":"Lehmann","year":"2000","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.075_bib0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol Today"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.075_bib0225","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.4049\/jimmunol.177.7.4636","article-title":"Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy","volume":"177","author":"Bodas","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.075_bib0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0035-9203(01)90344-X","article-title":"Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines","volume":"95","author":"Babaloo","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.075_bib0235","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","article-title":"IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis","volume":"12","author":"Bacellar","year":"2000","journal-title":"Cytokine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12008274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12008274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:55:55Z","timestamp":1687514155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12008274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":47,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X12008274"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}